325 related articles for article (PubMed ID: 21356293)
1. Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells.
Mohammadi Z; Abolhassani M; Dorkoosh FA; Hosseinkhani S; Gilani K; Amini T; Najafabadi AR; Tehrani MR
Int J Pharm; 2011 May; 409(1-2):307-13. PubMed ID: 21356293
[TBL] [Abstract][Full Text] [Related]
2. In vivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung.
Mohammadi Z; Dorkoosh FA; Hosseinkhani S; Gilani K; Amini T; Najafabadi AR; Tehrani MR
Int J Pharm; 2011 Dec; 421(1):183-8. PubMed ID: 21979252
[TBL] [Abstract][Full Text] [Related]
3. Characterization of folate-chitosan-DNA nanoparticles for gene therapy.
Mansouri S; Cuie Y; Winnik F; Shi Q; Lavigne P; Benderdour M; Beaumont E; Fernandes JC
Biomaterials; 2006 Mar; 27(9):2060-5. PubMed ID: 16202449
[TBL] [Abstract][Full Text] [Related]
4. Stability studies of chitosan-DNA-FAP-B nanoparticles for gene delivery to lung epithelial cells.
Mohammadi Z; Dorkoosh FA; Hosseinkhani S; Amini T; Rahimi AA; Najafabadi AR; Tehrani MR
Acta Pharm; 2012 Mar; 62(1):83-92. PubMed ID: 22472451
[TBL] [Abstract][Full Text] [Related]
5. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency.
Gao Y; Xu Z; Chen S; Gu W; Chen L; Li Y
Int J Pharm; 2008 Jul; 359(1-2):241-6. PubMed ID: 18479851
[TBL] [Abstract][Full Text] [Related]
6. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Lu HD; Zhao HQ; Wang K; Lv LL
Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
[TBL] [Abstract][Full Text] [Related]
7. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
Eur J Pharm Biopharm; 2009 Feb; 71(2):257-63. PubMed ID: 18955137
[TBL] [Abstract][Full Text] [Related]
8. Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity.
Gao JQ; Zhao QQ; Lv TF; Shuai WP; Zhou J; Tang GP; Liang WQ; Tabata Y; Hu YL
Int J Pharm; 2010 Mar; 387(1-2):286-94. PubMed ID: 20035848
[TBL] [Abstract][Full Text] [Related]
9. Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.
Gao S; Chen J; Dong L; Ding Z; Yang YH; Zhang J
Eur J Pharm Biopharm; 2005 Aug; 60(3):327-34. PubMed ID: 15894474
[TBL] [Abstract][Full Text] [Related]
10. Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles.
Zhao X; Yu SB; Wu FL; Mao ZB; Yu CL
J Control Release; 2006 May; 112(2):223-8. PubMed ID: 16556468
[TBL] [Abstract][Full Text] [Related]
11. [Chitosan nanoparticles as gene vector: effect of particle size on transfection efficiency].
Yang XR; Zong L; Yuan XY
Yao Xue Xue Bao; 2007 Jul; 42(7):774-9. PubMed ID: 17882964
[TBL] [Abstract][Full Text] [Related]
12. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
[TBL] [Abstract][Full Text] [Related]
13. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
15. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
Douglas KL; Piccirillo CA; Tabrizian M
J Control Release; 2006 Oct; 115(3):354-61. PubMed ID: 17045691
[TBL] [Abstract][Full Text] [Related]
16. A novel PEGylation of chitosan nanoparticles for gene delivery.
Zhang Y; Chen J; Zhang Y; Pan Y; Zhao J; Ren L; Liao M; Hu Z; Kong L; Wang J
Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):197-204. PubMed ID: 17147512
[TBL] [Abstract][Full Text] [Related]
17. Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting.
Jiang HL; Kim YK; Arote R; Jere D; Quan JS; Yu JH; Choi YJ; Nah JW; Cho MH; Cho CS
Int J Pharm; 2009 Jun; 375(1-2):133-9. PubMed ID: 19481699
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells.
Elfinger M; Maucksch C; Rudolph C
Biomaterials; 2007 Aug; 28(23):3448-55. PubMed ID: 17475321
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells.
Weecharangsan W; Opanasopit P; Ngawhirunpat T; Apirakaramwong A; Rojanarata T; Ruktanonchai U; Lee RJ
Int J Pharm; 2008 Feb; 348(1-2):161-8. PubMed ID: 17714894
[TBL] [Abstract][Full Text] [Related]
20. Preparation of galactosylated chitosan/tripolyphosphate nanoparticles and application as a gene carrier for targeting SMMC7721 cells.
Jiang H; Wu H; Xu YL; Wang JZ; Zeng Y
J Biosci Bioeng; 2011 Jun; 111(6):719-24. PubMed ID: 21334972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
